Healthcare provider profile · identity verified

Kevin Scott Mccann, MD

Family Practice · LAVALETTE, WV · NPI 1346201191

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	353	96
Atorvastatin Calcium	Atorvastatin Calcium	324	88
Amlodipine Besylate	Amlodipine Besylate	288	74
Levothyroxine Sodium	Levothyroxine Sodium	268	61
Losartan Potassium	Losartan Potassium	262	71
Metoprolol Succinate	Metoprolol Succinate	253	67
Pravastatin Sodium	Pravastatin Sodium	235	59
Rosuvastatin Calcium	Rosuvastatin Calcium	220	65
Lisinopril	Lisinopril	211	57
Potassium Chloride	Potassium Chloride	182	55
Furosemide	Furosemide	173	49
Hydrochlorothiazide	Hydrochlorothiazide	166	47
Gabapentin	Gabapentin	146	25
Tramadol Hcl	Tramadol Hcl	142	23
Glipizide Er	Glipizide	129	29
Metformin Hcl	Metformin Hcl	123	34
Duloxetine Hcl	Duloxetine Hcl	117	26
Alprazolam	Alprazolam	112	16
Eliquis	Apixaban	101	24
Fluticasone Propionate	Fluticasone Propionate	101	39
Ozempic	Semaglutide	97	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	93	19
Metformin Hcl Er	Metformin Hcl	93	21
Montelukast Sodium	Montelukast Sodium	92	22
Tamsulosin Hcl	Tamsulosin Hcl	92	23
Sertraline Hcl	Sertraline Hcl	89	26
Clopidogrel	Clopidogrel Bisulfate	84	23
Allopurinol	Allopurinol	79	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	25
Lorazepam	Lorazepam	73	11
Zolpidem Tartrate	Zolpidem Tartrate	73	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	71	21
Pantoprazole Sodium	Pantoprazole Sodium	71	20
Spironolactone	Spironolactone	70	17
Donepezil Hcl	Donepezil Hcl	65	16
Paroxetine Hcl	Paroxetine Hcl	64	15
Valsartan	Valsartan	64	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	58	16
Nifedipine Er	Nifedipine	58	15
Trazodone Hcl	Trazodone Hcl	58	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	suppressed
Mirtazapine	Mirtazapine	57	16
Jardiance	Empagliflozin	53	15
Alendronate Sodium	Alendronate Sodium	52	15
Ventolin Hfa	Albuterol Sulfate	45	suppressed
Atenolol	Atenolol	43	12
Escitalopram Oxalate	Escitalopram Oxalate	43	13
Lovastatin	Lovastatin	43	11
Bupropion Xl	Bupropion Hcl	41	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Prednisone	Prednisone	39	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	38	11
Ezetimibe	Ezetimibe	37	12
Famotidine	Famotidine	36	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	36	suppressed
Finasteride	Finasteride	35	suppressed
Methocarbamol	Methocarbamol	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	33	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	32	suppressed
Carvedilol	Carvedilol	32	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	31	11
Synthroid	Levothyroxine Sodium	30	suppressed
Mounjaro	Tirzepatide	29	suppressed
Simvastatin	Simvastatin	28	suppressed
Celecoxib	Celecoxib	27	11
Glipizide	Glipizide	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	suppressed
Novolog Flexpen	Insulin Aspart	26	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	25	suppressed
Labetalol Hcl	Labetalol Hcl	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Clonazepam	Clonazepam	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Nystatin	Nystatin	18	13
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Hydralazine Hcl	Hydralazine Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	15
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	16	suppressed
Azithromycin	Azithromycin	15	12
Diazepam	Diazepam	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Repaglinide	Repaglinide	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	12
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Digoxin	Digoxin	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error